Found 10 matching trials
Safety and Pharmacokinetics of SANGUINATE⢠in Sickle Cell Disease (SCD) Patients
N/AProlong proposes to test safety, tolerability and pharmacokinetics of SANGU...
Location
Rambam Health Care Campus
Safety and Effect of SANGUINATE⢠Infusion in Patients at Risk of Delayed Cerebral Ischemia (DCI) Following Subarachnoid Hemorrhage (SAH)
PHASE2Safety and effect of SANGUINATE on patients DCI following SAH....
Location
Barnes Jewish Hospital/Washington University
A Study of SANGUINATE for the Treatment of Vaso-occlusive Crisis (VOC) in Adult Sickle Cell Disease Patients
PHASE2Safety and effect of SANGUINATE on Sickle Cell Disease patients experiencin...
Location
Multiple Locations
An Assessment of the Safety and Pharmacokinetics of Ascending Doses of SANGUINATE⢠in Healthy Volunteers.
PHASE1Safety assessment of SANGUINATE⢠in Healthy Volunteers....
Location
Rambam Health Care Facility
SANGUINATE⢠in Sickle Cell Disease Associated Leg Ulcer
PHASE2SANGUINATE⢠Sickle Cell Disease associated Leg Ulcers....
Location
General Hospital Plaza de la Salud
A Study on SANGUINATE⢠for the Reduction of Delayed Graft Function in Kidney Transplant Patients
PHASE2Safety and efficacy study of SANGUINATE on reduction of delayed graft funct...
Location
Multiple Locations
Study of SANGUINATE⢠Versus Hydroxyurea in Sickle Cell Disease (SCD) Patients
PHASE1The purpose of this study is to compare the safety of SANGUINATE⢠versus Hy...
A Phase 1 Safety Study of SANGUINATE⢠In Patients With Acute Severe Anemia.
PHASE1In this open-label study, eligible and consenting adult patients admitted t...
Location
Brookwood Princeton Baptist
Study of SANGUINATE⢠In the Treatment of Sickle Cell Disease Patients With Vaso-Occlusive Crisis
PHASE2Safety and effect of SANGUINATE on Sickle Cell Disease patients experiencin...
Efficacy and Safety of SANGUINATE⢠for Reduction of Delayed Graft Function in Patients Receiving a Kidney Transplant
PHASE2Safety and efficacy study of SANGUINATE on reduction of delayed graft funct...
Location
Mayo Clinic Phoenix